
-
Shan PENG
Regional Partner / Wuhan
-
Tel +86-27-5942-5163
Email pengshan@zhonglun.com
-
Practices
Chinese Mainland Capital Markets, Private Equity & Investment Funds, Litigation & Arbitration
Shan PENG
Since Ms. Peng started to practice law nearly a decade ago, she has led projects with significant market influence and accumulated rich experience in the field of capital markets. She is skilled in domestic IPOs, transfer of listing, refinancing of domestic listed companies, major asset restructuring, listing on the NEEQ, Beijing Stock Exchange listing, private placement, investment, and mergers and acquisitions.
Representative Matters
Domestic Listing
Managed the IPO of Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
Managed the first public offering of select tier shares by Taixiang
Managed the listing of Taixiang shares on the Beijing Stock Exchange (BSE)
Managed the transfer of listing of Taixiang (301192.SZ) to ChiNext, the first of its kind in China
Managed the listing of an enterprise in Wuhan on the BSE (to be declared)
Managed the listing of an enterprise in Hunan on the BSE (to be declared)
Managed the listing of an enterprise in Wuhan on the SSE STAR Market (to be declared)
Mergers, Acquisitions, Restructurings, and Refinancings of Listed Companies
Managed GotoBiopharm's public convertible bond program
Managed Taixiang's acquisition of controlling interest in Hongma Technology and major asset restructuring
Managed Xingfa Group's refinancing projects, including the issuance of CNY 800 million corporate bonds and CNY 2 billion ultra-short-term financing bonds
Participated in the major asset reorganization project of Dinglong
Managed Xingfa Group's acquisition of Inner Mongolia Tenglong, Jingzhou Jinghua, Maple Leaf Chemical and other domestic listed companies
National Equities Exchange and Quotations (NEEQ)
Participated in the listing and public transfer of stocks in nearly 20 enterprises on the National Equities Exchange and Quotations (NEEQ), including Precision New Power, Zhuo Yue Technology, Taixiang Stock, Dacheng Science and Technology, Xinkegu, Xianlu Medicine, Ulan Voyage School, Aidi Science and Technology, Sang Zhiyuan, Zhongsheng Water Conservation, Hexite, EWT, Carter Stock, Radiate, Dayang Yitian, and so on
Advised on the public offering and transfer of the shares of Taixiang Stock to the National Stock Transfer System, and the listing of Taixiang Stock on the BSE
Private Investment and Financing
Participated in the investment and establishment of sub-funds by state-owned funds, the establishment of merger and acquisition funds by many listed companies such as Ma Yinglong, Xingfa Group, Tianyu Information, Yanhua Intelligence, and Xingfa Group, as well as the fundraising and establishment of private equity funds, registration and filing, and investment due diligence and post-investment management , and mergers and acquisitions of PE funds
Corporate Compliance
Provided legal services for listed companies including Xingfa Group, Dinglong, GotoBiopharm, Taixiang, and Tianyu Information for internal control standardization and information disclosure compliance matters
Provided legal services for listed companies such as Luban Pharmaceutical, Dayang Yitian, and Reddit on optimization of corporate governance structure
Equity Incentive
Managed equity incentive projects for Xingfa Group, Dinglong, Tianyu, GotoBiopharm, Taixiang, and other listed companies
Provided legal services for equity incentives for Carter, EWT, Luban Pharmaceutical, Reddit, and other companies
-
Bar Admissions/Professional Qualifications
PRC Bar, 2015
-
Education
Master of Law, Central China Normal University, 2011 to 2014
-
Professional Experience
Regional partner, non-equity partner, and associate, Zhong Lun Law Firm, February 2015 to present
Legal Officer, Wuhan Academy of Agricultural Sciences, June 2014-October 2014 -
Languages
Chinese
English